Literature DB >> 21383745

Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression.

Mina J Bissell1, William C Hines.   

Abstract

Tumors are like new organs and are made of multiple cell types and components. The tumor competes with the normal microenvironment to overcome antitumorigenic pressures. Before that battle is won, the tumor may exist within the organ unnoticed by the host, referred to as 'occult cancer'. We review how normal tissue homeostasis and architecture inhibit progression of cancer and how changes in the microenvironment can shift the balance of these signals to the procancerous state. We also include a discussion of how this information is being tailored for clinical use.

Entities:  

Mesh:

Year:  2011        PMID: 21383745      PMCID: PMC3569482          DOI: 10.1038/nm.2328

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  133 in total

1.  Disruption of 3D tissue integrity facilitates adenovirus infection by deregulating the coxsackievirus and adenovirus receptor.

Authors:  M Anders; R Hansen; R-X Ding; K A Rauen; M J Bissell; W Michael Korn
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-07       Impact factor: 11.205

2.  Mediation of wound-related Rous sarcoma virus tumorigenesis by TGF-beta.

Authors:  M H Sieweke; N L Thompson; M B Sporn; M J Bissell
Journal:  Science       Date:  1990-06-29       Impact factor: 47.728

Review 3.  Microenvironmental regulation of metastasis.

Authors:  Johanna A Joyce; Jeffrey W Pollard
Journal:  Nat Rev Cancer       Date:  2008-03-12       Impact factor: 60.716

4.  Axillary lymph node metastasis from an occult breast cancer.

Authors:  J Patel; T Nemoto; D Rosner; T L Dao; J W Pickren
Journal:  Cancer       Date:  1981-06-15       Impact factor: 6.860

5.  Endothelial cell migration and vascular endothelial growth factor expression are the result of loss of breast tissue polarity.

Authors:  Amy Chen; Ileana Cuevas; Paraic A Kenny; Hiroshi Miyake; Kimberley Mace; Cyrus Ghajar; Aaron Boudreau; Mina J Bissell; Mina Bissell; Nancy Boudreau
Journal:  Cancer Res       Date:  2009-08-04       Impact factor: 12.701

6.  Stromal gene expression predicts clinical outcome in breast cancer.

Authors:  Greg Finak; Nicholas Bertos; Francois Pepin; Svetlana Sadekova; Margarita Souleimanova; Hong Zhao; Haiying Chen; Gulbeyaz Omeroglu; Sarkis Meterissian; Atilla Omeroglu; Michael Hallett; Morag Park
Journal:  Nat Med       Date:  2008-04-27       Impact factor: 53.440

7.  Beta1 integrin inhibition dramatically enhances radiotherapy efficacy in human breast cancer xenografts.

Authors:  Catherine C Park; Hui J Zhang; Evelyn S Yao; Chong J Park; Mina J Bissell
Journal:  Cancer Res       Date:  2008-06-01       Impact factor: 12.701

Review 8.  The tumor microenvironment and its role in promoting tumor growth.

Authors:  T L Whiteside
Journal:  Oncogene       Date:  2008-10-06       Impact factor: 9.867

9.  Normal and tumor-derived myoepithelial cells differ in their ability to interact with luminal breast epithelial cells for polarity and basement membrane deposition.

Authors:  Thorarinn Gudjonsson; Lone Rønnov-Jessen; René Villadsen; Fritz Rank; Mina J Bissell; Ole William Petersen
Journal:  J Cell Sci       Date:  2002-01-01       Impact factor: 5.285

10.  Oxidative stress promotes myofibroblast differentiation and tumour spreading.

Authors:  Aurore Toullec; Damien Gerald; Gilles Despouy; Brigitte Bourachot; Melissa Cardon; Sylvain Lefort; Marion Richardson; Guillem Rigaill; Maria-Carla Parrini; Carlo Lucchesi; Dorine Bellanger; Marc-Henri Stern; Thierry Dubois; Xavier Sastre-Garau; Olivier Delattre; Anne Vincent-Salomon; Fatima Mechta-Grigoriou
Journal:  EMBO Mol Med       Date:  2010-06       Impact factor: 12.137

View more
  597 in total

Review 1.  Macrophage-tumor crosstalk: role of TAMR tyrosine kinase receptors and of their ligands.

Authors:  Thomas Schmidt; Isabel Ben-Batalla; Alexander Schultze; Sonja Loges
Journal:  Cell Mol Life Sci       Date:  2011-11-11       Impact factor: 9.261

2.  Entrainment of breast (cancer) epithelial cells detects distinct circadian oscillation patterns for clock and hormone receptor genes.

Authors:  Stefano Rossetti; Joseph Esposito; Francesca Corlazzoli; Alex Gregorski; Nicoletta Sacchi
Journal:  Cell Cycle       Date:  2012-01-15       Impact factor: 4.534

3.  Gene signatures revisited.

Authors:  Stuart G Baker
Journal:  J Natl Cancer Inst       Date:  2012-01-18       Impact factor: 13.506

Review 4.  The evolution of endothelial regulatory paradigms in cancer biology and vascular repair.

Authors:  Joseph W Franses; Elazer R Edelman
Journal:  Cancer Res       Date:  2011-12-05       Impact factor: 12.701

Review 5.  Recent developments in myofibroblast biology: paradigms for connective tissue remodeling.

Authors:  Boris Hinz; Sem H Phan; Victor J Thannickal; Marco Prunotto; Alexis Desmoulière; John Varga; Olivier De Wever; Marc Mareel; Giulio Gabbiani
Journal:  Am J Pathol       Date:  2012-03-02       Impact factor: 4.307

6.  Cytometric comparisons between circulating tumor cells from prostate cancer patients and the prostate-tumor-derived LNCaP cell line.

Authors:  Daniel C Lazar; Edward H Cho; Madelyn S Luttgen; Thomas J Metzner; Maria Loressa Uson; Melissa Torrey; Mitchell E Gross; Peter Kuhn
Journal:  Phys Biol       Date:  2012-02-03       Impact factor: 2.583

7.  Stochastic modeling reveals an evolutionary mechanism underlying elevated rates of childhood leukemia.

Authors:  Andrii I Rozhok; Jennifer L Salstrom; James DeGregori
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-11       Impact factor: 11.205

Review 8.  Genetics of metastasis: melanoma and other cancers.

Authors:  Noel Turner; Olivia Ware; Marcus Bosenberg
Journal:  Clin Exp Metastasis       Date:  2018-05-02       Impact factor: 5.150

9.  Targeting myeloid-derived suppressor cells using a novel adenosine monophosphate-activated protein kinase (AMPK) activator.

Authors:  Prashant Trikha; Robert L Plews; Andrew Stiff; Shalini Gautam; Vincent Hsu; David Abood; Robert Wesolowski; Ian Landi; Xiaokui Mo; John Phay; Ching-Shih Chen; John Byrd; Michael Caligiuri; Susheela Tridandapani; William Carson
Journal:  Oncoimmunology       Date:  2016-07-25       Impact factor: 8.110

Review 10.  Tackling tumor heterogeneity and phenotypic plasticity in cancer precision medicine: our experience and a literature review.

Authors:  Shijie Sheng; M Margarida Bernardo; Sijana H Dzinic; Kang Chen; Elisabeth I Heath; Wael A Sakr
Journal:  Cancer Metastasis Rev       Date:  2018-12       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.